FedQuery
ActivePresolicitation

Biochemical Antibiotics Susceptibility Testings

Solicitation #
W81K0219Q0199
Posted
Jul 15, 2019
Response deadline
Aug 21, 2019
Archive date
Sep 5, 2019
NAICS
PSC
65
Place of performance
KOR
Contact
Tae H Kim · [email protected]

Description

The Regional Health Contracting Office - Pacific (RHCO-P), Hawaii intends to issue a solicitation on or about 22 July 2019 for an Indefinite Delivery Indefinite Quantity type contract with Firm-Fixed Prices for Biochemical Antibiotics Susceptibility Testings for Brian Allgood Army Community Hospital, Korea. The contract shall comply with all terms, conditions, special requirements and conditions, and specifications contained in the solicitation or incorporated by reference. The NAICS code for this procurement is 325413 - In-Vitro Diagnostic Substance Manufacturing. The annual size standard is 1,250 employees. This procurement will be solicited as unrestricted with full and open competition. The solicitation package will be available on the Federal Business Opportunity website (http://www.fedbizopps.gov) on or about 22 July 2019. No paper copies of the solicitation will be issued and no solicitation mailing list will be compiled. The Contract Specialist is Mr. Tae Kim, [email protected].

View on SAM.gov (attachments & response) ↗

More active opportunities in NAICS 325413

TitleAgencyTypeNAICSPostedDeadline
6550--Blood Type IVD ReagentsVETERANS AFFAIRS, DEPARTMENT OFCombined Synopsis/Solicitation325413Jul 14, 2026Jul 22, 2026(6d)
6550--NOITSS - Zeus Scientific Borrelia MTTT Lyme Elisa TestingVETERANS AFFAIRS, DEPARTMENT OFSpecial Notice325413Jul 14, 2026Jul 22, 2026(7d)
Notice of Award to Meridian BioscienceDEPT OF THE ARMYAward Notice325413Jul 14, 2026
Blood Bank Reagents - New Base Plus Four Option Year ContractVETERANS AFFAIRS, DEPARTMENT OFCombined Synopsis/Solicitation325413Jul 14, 2026Aug 10, 2026(25d)
ALCOR iSED ESR Reagents, Consumables, and Service / Warranty for Lab HematologyVETERANS AFFAIRS, DEPARTMENT OFAward Notice325413Jul 13, 2026
Biochemical Antibiotics Susceptibility Testings · FedQuery